CROI kicks off with Walensky chat about US response to COVID-19
Click Here to Manage Email Alerts
The Conference on Retroviruses and Opportunistic Infections begins this weekend and is being held for a third consecutive year as an all-virtual meeting because of COVID-19.
The conference, which runs from Feb. 12 to 16, will host CDC Director Rochelle P. Walensky, MD, MPH, on Sunday for a discussion on the United States response to the pandemic.
“CROI is always interesting and worthwhile,” Infectious Disease News Chief Medical Editor Paul A. Volberding, MD, told Healio. “But we all do hope we can get back to actual meetings to regain that hallway gossip stream of information — often the best education at the meeting.”
Established in 1993, CROI has traditionally been dominated by emerging research on HIV/AIDS, hepatitis and other viral infections. The program has expanded over the past 3 years to include presentations on SARS-CoV-2.
Volberding said he expects the highlights this year to include a robust discussion of HPV and anal cancer to coincide with the results of the ANCHOR trial.
“In overall terms, I expect we will hear a lot of COVID-19, with and without HIV coinfection,” Volberding said. “I would guess the work in that area is at least somewhat displacing new HIV developments per se and that itself might be worth exploring at CROI.”
Visit Healio.com/ID throughout the week to read the latest news. You can read more than a decade’s worth of coverage of CROI by clicking here.
The meeting will continue with an additional 3 days of symposia on Feb. 22, 23 and 24.
Collapse
Healio Interviews.
Click Here to Manage Email Alerts